SEREXIA https://www.serexia.com Empowering Healthcare with Strategy, Science & Technology Thu, 27 Aug 2026 21:23:59 +0000 en-US hourly 1 https://wordpress.org/?v=7.1 https://www.serexia.com/wp-content/uploads/2025/04/cropped-Primary-JPEG-32x32.jpg SEREXIA https://www.serexia.com 32 32 A few selected publications SEREXIA leadership authored https://www.serexia.com/a-few-selected-publications-serexia-leadership-authored/ https://www.serexia.com/a-few-selected-publications-serexia-leadership-authored/#respond Thu, 27 Aug 2026 21:23:59 +0000 https://www.serexia.com/?p=173223 A systematic review to summarize treatment patterns, guidelines, and characteristics of patients with renal cell carcinoma in the Asia-Pacific region.

So TH, Sharma S, Parij R, Spiteri C, Chawla E, Pandey P, et al. Expert Review of Anticancer Therapy. 2023;23(8):853-63.

Evaluation of Quality of Pharmacoeconomic Studies in Asia-Pacific Region and Identification of Influencing Variables.

Pandey P, Pandey RD, Shah V. Value in health regional issues.2018;15:70-5.

A systematic literature review of the epidemiology, clinical, economic and humanistic burden in recurrent respiratory papillomatosis.

Ovcinnikova O, Engelbrecht K, Verma M, Pandey R, Morais E. Respiratory Research. 2024;25(1):430.

Patient-reported outcome measurement and reporting for patients with advanced renal cell carcinoma: a systematic literature review.

Motzer RJ, Rane PP, Saretsky TL, Pawar D, Nguyen AM, Sundaram M, et al. European Urology. 2023.

Efficacy of Anti-Alzheimer’s (AD) Drugs in Cognitive Improvement: A Network Meta-Analysis (NMA) of Randomized Controlled Trials (RCTs).

Pandey P, Pawar D, Dhayalan S, Pandey R. Value in Health. 2023;26(12):S30.

Epidemiology, treatment patterns, and humanistic and economic burden of biliary tract carcinoma: A systematic and targeted literature review.

Kamble S, Desai K, Joo S, Pandey P, Swami S, Habila M, et al. Journal of Clinical Oncology. 2024;42(3_suppl):443.

Assessing the Epidemiology, Treatment Patterns, and Economic Impact of Marginal Zone Lymphoma: A Review of the Literature.

Squires P, Saini P, Pandey P, Pandey R, Hall A, Ryland KE, et al. Blood. 2022;140(Supplement 1):11987–9.

Indirect Treatment Comparison of SGLT2 Inhibitor Monotherapy in Patients with Uncontrolled Type 2 Diabetes on Diet/Exercise or Metformin.

Pandey P, Pandey R, Dhagale P, Shah V. Value in Health. 2019;22:S142–3.

Developing A Consolidated Checklist (Strwe-Retro) to Assess the Reporting Quality of Real-world Evidence Studies Based on Retrospective Data Analyses.

Pandey R, Baum E, Ma H, Pandey P, Dhagale P, Sawant A, et al. Value in Health. 2018;21:S211.

A Structured Literature Review Investigating the Current Treatment Landscape in Patients with Richter’s Transformation (2011–2021).

Prescott J, Pandey P, Hall A, Nathani J, Pandey R, Ryland KE, et al. Blood. 2022;140(Supplement 1):12418–20.

]]>
https://www.serexia.com/a-few-selected-publications-serexia-leadership-authored/feed/ 0
Meet SEREXIA at DIA 2025 Global Annual Meeting https://www.serexia.com/meet-serexia-at-dia-2025-global-annual-meeting/ https://www.serexia.com/meet-serexia-at-dia-2025-global-annual-meeting/#respond Sun, 15 Jun 2025 10:35:00 +0000 https://www.serexia.com/?p=122860 📍Washington DC, USA
📅June 15–19, 2025

SEREXIA is proud to announce our participation in the DIA 2025 Global Annual Meeting — the premier event that unites global experts in pharmaceuticals, biotechnology, regulatory science, and health technology.

As a data-driven consultancy focused on health economics, evidence synthesis, data science, and strategic insights, SEREXIA partners with pharma, medtech, payers, healthcare providers, and social organizations to solve real-world challenges across the healthcare ecosystem.

Whether you’re looking to:

  • Strengthen your evidence generation &dissemination strategies
  • Build compelling market access strategies
  • Derive insights from real-world data
  • Find innovative AI and Tech solutions
    — SEREXIA is here to help.

DIA 2025 offers an ideal opportunity to explore how we can collaborate to unlock value from your data and deliver smarter, evidence-informed decisions.

Let’s connect!
If you’re attending DIA 2025 and want to learn how SEREXIA can support your goals, we’d love to schedule a meeting. Reach out to us at connect@serexia.com.

Contact US Button

Together, let’s drive meaningful change in healthcare.

]]>
https://www.serexia.com/meet-serexia-at-dia-2025-global-annual-meeting/feed/ 0
SEREXIA Inaugurates Its New Office Space https://www.serexia.com/serexia-inaugurates-its-new-office-space/ https://www.serexia.com/serexia-inaugurates-its-new-office-space/#respond Wed, 09 Apr 2025 10:17:00 +0000 https://www.serexia.com/?p=122857 📍Bangalore

📅9th April 2025

We are thrilled to announce the inauguration of SEREXIA’s new office space at Mantri Commercio, Sarjapur Outer Ring Rd, Bengaluru— a major milestone in our journey to becoming a trusted partner for designing data-driven solutions for healthcare ecosystem.

The new space reflects our commitment to building a collaborative, creative, and purpose-driven environment where ideas can flourish, and impactful solutions can take shape. Designed for flexibility and growth, the office will serve as the central hub for our team.

This marks not just the beginning of a new workspace, but a new phase in SEREXIA’s mission — to bridge data with decision-making and bring clarity to complexity in healthcare.

Stay tuned for more updates as we grow, collaborate, and create impact!

]]>
https://www.serexia.com/serexia-inaugurates-its-new-office-space/feed/ 0